Sentrx to Exhibit at the 46th DIA Annual Meeting

Little Falls, NJ  - Sentrx, the leading provider of drug safety services to the life science industry, will exhibit at the upcoming 46th DIA Annual Meeting, June 13-17, 2010 in Washington, DC.  Sentrx will be featuring CROplus, a comprehensive channel partner solution for growth oriented clinical research organizations as well as their full service pharmacovigilance and drug safety solutions. Visit Sentrx at booth #2039 at DIA to learn how their services and solutions enhance and optimize pharmacovigilance and drug safety needs.

 

Sentrx will have onsite experts from its Pharmacovigilance unit, as well as members of their Medical Affairs and Regulatory Affairs service departments.  Also available will be member of Sentrx Technology Services Group to discuss recent trends and developments in safety technology, including Oracle’s safety roadmap and the implication of the proposed Phase Forward acquisition.

 

The DIA Annual Meeting is the premier event for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. There is no other industry meeting of its kind that can rival the breadth and depth of experience that this meeting delivers. With 25 content-area tracks, 330 sessions, and 20 tutorials, presentations are geared to attendees at all disciplines, works settings, and experience levels.

Doreen Lechner, PhD

EVP Pharmacovigilance Client Services

Doreen.lechner@sentrx.com